In production
The same result, owed to a doctor and to a lawyer
This is the page where the release model stops being a diagram. Everything else on this site describes how a diagnostic result is scoped, released, and recorded. What follows is that model carrying work for a named company, published with their agreement.
Neuroglympse
Neuroglympse assesses mild traumatic brain injury and the conditions that follow it. The assessment is built to reach the patient rather than require the patient to reach a specialist centre: ocular-motor testing, remote therapeutic monitoring, and telemedicine consultation. It runs a neurodiagnostic brain information management system — the brain-injury counterpart of the laboratory systems described elsewhere on this site — on Metaclinic.
Mild traumatic brain injury is the case that makes the release problem impossible to avoid. A concussion is easy to miss and the window in which it is most readily detected is short, so the assessment has to happen quickly and close to the patient. The record it produces is then very often owed to two parties at once who have nothing else in common: the clinician treating the patient, and the attorney of record in a claim arising from the same accident. They are entitled to different parts of it, on different authority, and the second is not entitled to it merely for asking.

What runs on Metaclinic
- Scoped attorney access
- The attorney of record receives the part of the record their authorization actually names, on a stated basis, for the matter in front of them. Not a role that outlives the case, and not the entire chart because one page of it was relevant.
- Liens and letters of protection
- Care delivered under a letter of protection carries a charge and lien ledger that travels with the case, rather than being reconstructed out of email at the moment of settlement.
- Patient access and enrollment
- Patients enroll directly and reach their own results without asking anyone to release them, which is a legal requirement rather than a courtesy.
The reason this scales across the country is unglamorous. Because each of those decisions is made in advance and enforced in the database rather than in a policy document, adding a market, a practice, or another firm is an onboarding step instead of a fresh judgement about who may see what. The answer exists before anyone asks for it.
NeuroglympseLiens and letters of protectionAttorneys of record
Which stakeholder is currently asking you for data you cannot easily give them?
That is the useful first conversation, and it is a short one. Bring the laboratories, the practices, and the thing that breaks today.
service@meta.clinic Read the release model first